About ADPA Laboratory
API Laboratory #85432
CAP #9110420
Anatomic Pathology CLIA #03D2088150
Clinical Pathology CLIA #03D2294971
Pathologist-Led Excellence in Full-Service Diagnostic Laboratory Testing
From histology to molecular testing, ADPA combines advanced technology and expert oversight to deliver accurate, timely diagnoses across multiple specialties.
Founded in Tucson, ADPA Laboratory is a pathologist-led, CLIA-certified and CAP-accredited diagnostic lab serving providers across a broad range of specialties. Our mission is to deliver precise, timely results that empower clinical decision-making and patient care.
Cases/Year
Avg. Turnaround Time
Meet Our Leadership & Team
Anil R. Prasad, MD, FCAP, FASCP
President & Chief Pathologist
Licensed in: AL, AZ, CA, CO, MI, MS, NV, TN, TX, WI
Current Appointments:
- President of Arizona Diagnostic Pathology Associates since 2020, leading a premier pathology practice in Southern Arizona.
- Board-certified in Anatomic, Clinical, and Cytopathology by the American Board of Pathology.
- Fellowship-trained at the Mayo Clinic in GI/GU & Molecular Pathology and at Henry Ford Hospital in Cytopathology.
- Over 25 years of diagnostic experience across hospital, academic, and private practice settings.
- Associate Professor of Clinical Pathology at the University of Arizona Health Sciences Center.
- Author of over 70 peer-reviewed scientific publications, book chapters, and abstracts.
- Founding Co-Director of the Molecular Pathology Fellowship at the VA Health System in Tucson.
- Former Vice Chair of Pathology at St. Mary’s Hospital and Medical Director for multiple labs.
- Recognized repeatedly as one of Tucson’s Best Doctors by Tucson Lifestyle Magazine (2008–2022).
- Consultant to Roche-Ventana, PathAI, and several national advisory boards on diagnostics and biorepositories.
Anil R. Prasad
Full Curriculum Vitae
Education & Training
JULY 2000- JUNE 2001
Fellowship in Surgical Pathology with special emphasisin GI /GU Pathology & Molecular Pathology: Mayo Clinic, Rochester, MN
JULY 1999- JUNE 2000
Fellowship in Cytopathology, Henry Ford Hospital, Detroit, MI
JULY 1996- JUNE 1999
Residency in Anatomic/Clinical Pathology, Henry Ford Hospital, Detroit,
MI
MAY 1992
M.D. in Pathology Jawaharlal Institute of Postgraduate Medical
Education & Research (JIPMER), University of Pondicherry, India
APRIL 1985
M.B.B.S. (Bachelor of Armed Forces Medical College,
Medicine & Surgery) University of Pune, India
SEPT 2010
Business of Medicine Executive Course Eller School of Management, Tucson, AZ, USA
Medical Licensure
Arizona, Nevada, Wisconsin, Michigan
Board Certification (American Board of Pathology)
SEPT 2001
Board Certified in Anatomic and Clinical Pathology
SEPT 2002
Board Certified in Cytopathology
Chronology of Employment and Postgraduate Training
SEPT 2020- Present
President, Arizona Diagnostic Pathology Associates, PLLC
AUG 2013-JAN 2023
Staff Pathologist, Northwest Medical Center & Oro Valley Hospitals Tucson, AZ; Medical Director, Green Valley Hospital Laboratory
AUG 2010-Aug 2023
Consultant, Roche- Ventana Systems, Research & Assay Dev.
APRIL 2017-Present
Medical Director, Arizona Gastrointestinal Associates PLLC, Scottsdale, AZ
JUNE 2023-Present
Medical Director, Arizona State Urology, Glendale, AZ
JAN 2018-Jan 2023
Teaching Faculty Member & Preceptor, Burrell College of Osteopathic Medicine, Univ. of New Mexico
APRIL 2009-JUNE 2013
Staff Pathologist and Vice Chair of Pathology Dept. of Pathology, St. Mary’s Hospital, Tucson,AZ (300 bed community hospital)
Signing out routine surgicals and cytologiesincluding frozen sections, bone
marrows
CoveringAP/CP including Blood Bank, Microbiology. Laboratory Medical Director, Holy Cross Hospital, Nogales,AZ
Teaching Preceptor for medical students for “pathology elective” from AT Still School of Osteopathic Medicine
OCT 2004- MARCH 2009
Clinical Director, Pathology Research & Development Southern Arizona VA Health Care System, Tucson,AZ
OCT 2002-SEP 2004
Clinical Director of Surgical Pathology and Cytology Southern Arizona VA Health Care System, Tucson, AZ. Directed the Histopathology and Cytopathology sections
Established the first FNAC ( Fine Needle Aspiration Cytology) Clinic
OCT 2002- MAR 2009 Co Program Director of Molecular Pathology and Laboratory Services
Co- Director, Molecular Pathology Fellowship Program
Established ACGME accreditated Molecular Pathology Fellowship Program at Southern Arizona VA Health Care System.
Established & Developed FISH assays for Bladder Cancer, Her2-neu for Breast
Cancer & CLL.
AUG 2001-SEP 2002
Staff Pathologist Southern Arizona VA Health Care System, Tucson, AZ
MAR 2008- Present
Associate Professor of Clinical Pathology
University ofArizona Health Science Center
AUG 2001- FEB 2008 Assistant Professor of Clinical Pathology, University ofArizona Pathology Health Science Center
AUG 2001- Present
Consultant,Arizona Cancer Center, Tucson,Arizona
JULY 2000-JUNE 2001 Fellowship, Surgical Pathology with special emphasis on GI/GU Pathology & Molecular Pathology Mayo Clinic, Rochester, MN
JULY 1999-JUNE 2000
Fellowship, Cytopathology Henry Ford Hospital, Detroit, MI
JUNE 1996-JUN 1999
Resident in Pathology
Henry Ford Hospital, Detroit, MI
JULY 1995- MAR 1996
Assistant Professor in Pathology Pondicherry Dental College, University of Pondicherry, India
APRIL 1992-JUNE 1995 Senior Resident in Pathology JIPMER, Pondicherry, India
APRIL 1989- MAR 1992
Postgraduate Junior Resident in Pathology JIPMER Hospital, Pondicherry, India
JULY 1988- MARH 1989
Medical Officer in Charge Primary Health Care Center “Arogya”, Bangalore, India
MAY 1987-JUNE 1988
House Officer in Intensive Coronary Care Unit
Bangalore Heart Center, Bangalore, India
JULY1986- APRIL 1987
Senior House Officer (Resident Trainee) in Internal Medicine St. Martha’s Hospital, Bangalore, India
APRIL 1985-JUNE 1986 Clinical Rotatory Internship, St. Martha’s Hospital, Bangalore, India Clinical clerkship in Internal Medicine including Psychiatry, General Surgery – Orthopedics and Anesthesia, Obstetrics and Gynecology, Pediatrics, Community Medicine, Ophthalmology and Dermatology.
Honors and Awards
SEP 1989
Best Paper Award for papers presented (Alport’s syndrome) in the JIPMER (Jawaharlal Institute of Postgraduate Medical Education and Research) Scientific Society, Pondicherry, India.
SEP 1990
Received the Dr. Shantha Arogyados CERTIFICATE OF DISTINCTION for outstanding performance in the Annual Pathology Examination, conducted by K.J. Hospital, Madras for all postgraduate Pathology residents in South India.
APRIL 1992
FIRST RANK in the University M.D. Pathology examination, Pondicherry University, India.
APRIL 1992 Received the Dr. D.J. Reddy GOLD MEDAL for the best postgraduate resident in Pathology awarded by Pondicherry University, India.
JUNE 1992
Best Paper Award for papers presented (Giant Cell Tumors of Patella) in the JIPMER Scientific Society, Pondicherry, India.
1992 & 1993
Best Paper Award for papers presented on Aspiration Cytology of Intrathoracic Tumors in the Plenary Session of the 41st National Annual Conference of IAPM (Indian Association of Pathologists and Microbiologists) Pune, India and 22nd National Annual Conference of Indian Academy of Cytologists, Pune, India.
1993 & 1994
J.S.A. BEST TEACHER AWARD for being unanimously adjudged as most inspiring teacher by the JIPMER Undergraduate Medical Students Association.
2000 Award for Excellence (Honorable Mention) in Medical Photography, American Society of Clinical Pathologists (ASCP) Medical Photography Competition.
2003
Clinical Excellence Award for Special Clinical Contribution, SAVAHCS, Tucson, AZ
2006
Foreign Travel Grant Award by University of Arizona, Tucson, for international scholarly activity: Invited speaker & guest faculty at the Indian Division of International Academy of Pathology. Telepathology Case Presentation, Surgical Pathology of Head and Neck Tumors.
2007
THIRD PRIZE Univ. of Arizona Resident Research Forum Lerned Peltier Best Paper AWARD Prognostic Value of Immunohistopathological Analysis of Non-Well Differentiated Squamous Cell Cancer of the Skin
2007
SAVAHCS CLINICAL INVESTIGATOR OFTHE YEAR AWARD.
2008- 2022
Mentioned in Tucson Lifestyle Magazine: Tucson’s Best Doctors 2008 to 2014, 2016, 2018,2022
Professional Affiliations
1996- Present Fellow, American Society of Clinical Pathologists (ASCP)
1996- Present
Fellow, College of American Pathologists (CAP)
2000 -Present
American Medical Association (AMA)
1996- Present
United States and Canadian Academy of Pathology (USCAP)
2006- Present
AzTransNet Biorepository Research Workgroup Members
2003- Present
International Society of Biological & Environmental Repositories (ISBER)
2002- Present
Arizona Society of Pathologists (ASP)
2009-Present
Arizona Medical Association (ArMA)
Hospital Committee Service
2001- 2009
Surgical Pathology Quality Assurance Committee, SAVAHCS, Tucson, AZ
2003- 2009
Cancer Committee, SAVAHCS, Tucson, AZ
2005- 2009
VA Physicians Pay Panel Committee, SAVAHCS, Tucson, AZ
2005- 2009
VISN 18 New Investigator Research Grant Reviewer
2009- 2013
Surgical Pathology Quality Assurance Committee, St. Mary’s Hospital, Tucson, AZ
Extramural Service
2002 – Present
College of American Pathologists (CAP) Laboratory Inspector for Anatomic Pathology & Molecular Pathology
2008 – 2010
Member of ISBER 10th. Annual 2009 Meeting Organizing Committee
2006 – 2009
SARSEF Science Fair Judges for SAVAHCS
2008- 2009
Member of ISBER Biospecimen Research Working Group
2008 – Present
CAP Team Leader Laboratory Inspector
2009 – 2012 CAP Member Market Research Panel
2019-2023
President, Arizona Society of Pathologists
2022-Present
Executive Board Member, Pima County Medical Society
2010- 2014
Member, Mentors Panel, CAP Mentorship Program
2011- 2012
Member, CAP Learning and Development Tool Focus Group
2012- 2015
Appointed, Arizona Delegate to CAP House of Delegates
2012- Present
Appointed, Member, Board of Directors Pima County Medical Foundation
2012-Present
Chair, Planning Committee, Annual Meeting of Arizona Society of Pathologists
2015- Present
Chairman, Arizona State CAP Delegation
2019-2022
President, Association of Indian Pathologists in North America
2019
Appointed, Chairman of CAP House of Delegates Nominating Committee
2024
Member, Advisory Board Daiichi Sankyo
2025
Consultant Pathologist, PathAI
Publications
Peer Reviewed Published Abstracts & Papers
1. Jaisankar T., Garg BR, Reddy BSN, Bommi R, Prasad AR. Penile lupus vulgaris – a case report.
International Journal of Dermatology. 33(4):272-274;1994
2. Prasad AR, Narasimhan R, Sankaran V, Veliath AJ. Fine needle aspiration cytology in the diagnosis superficial lymphadenopathy – an analysis of 2418 cases. Diagnostic Cytopathology. 15(5):382-386;1995
3. Prasad AR, Ratnakar C, Veliath AJ K. Srinivasan K. Eccrine carcinoma of the forearm. International Journal of Dermatology. 34(12):859-860;1995
4. Prakash RM, Prasad AR., Sharma P. Seetharaman ML. Tuberculous pleurisy mimicking pleural
mesothelioma – A Case Report. JAPI. 43(3):223; 1995
5. Prasad AR, Bhatnagar RK, Ratnakar C, Veliath AJ. Alport’s Syndrome – a case report. The Indian Journal of Pathology and Microbiology. 39(3): 36-39;1996
6. Thappa MD, Garg RB, Prasad AR, Ratnakar C. Multiple leiomyoma cutis associated with Becker’s Nevus. Letter to Editor. Journal of Dermatology. 23(10):719-720;1996
7. Prasad AR, Ma CK, Lee MW, Amin MB. Significance of Acid- Mucin Secreting Columnar Cells in Gastroesophageal Junctional ( Cardiac) Mucosa. Modern Pathology 11 (1): 68; 1998
8. Prasad AR, Savera AT Zarbo RJ. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Archives Pathology &
Laboratory Medicine. 123(9):801-806;1999
9. Prasad AR, Ma CK. Nodular Regenerative hyperplasia of the liver: Report of three cases with hepatocellular carcinoma arising in one. American Journal of Gastroenterology. 9:2661-2662;1999
10. Prasad AR, Savera AT, Zarbo RJ. Antimitochondrial antibody – a diagnostic discriminant of salivary gland oncocytic tumors and acinic cell carcinomas. Modern Pathology 12(1): 130;1999
11. Prasad AR, Ramalingam P, Raju UR. Ductal carcinoma In-situ: Correlation of residual disease with margin status and Van Nuys Prognostic Index, Modern Pathology 12(1): 29;1999
12. Prasad AR, Amin MB, Randolph TL, Lee CS, Ma CK. Retrorectal cystic hamartoma: report of 5 cases with malignancy arising in two. Archive Pathology & Laboratory Medicine. 124(5):725-
729;2000
13. Zarbo RJ, Prasad AR, Regezi JA, Gown AM, Savera AT. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and
morphogenetic considerations. Archives Pathology & Laboratory. Medicine 124(3):401-405;2000
14. Ananthasubramanian K, Shurafa M, Prasad AR. Heparin induced thrombocytopenia. Review
article. Progress in Cardiovascular. Diseases 42(4):247-260;2000
15. Prasad AR, Amin MB, Randolph TL, Lee CS, Ma CK. Retrorectal cystic hamartoma: report of 5 cases with malignancy arising in two. Archives of Pathology & Laboratory Medicine 124(5):725-729;2000
16. Zarbo RJ, Prasad AR, RegeziJA, GownAM, SaveraAT. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Archives of Pathology & Laboratory Medicine 124(3);401-405;2000
17. Ananthasubramanian K, Shurafa M, Prasad AR. Heparin induced thrombocytopenia. Progress in Cardiovascular Disease 42(4):247;2000
18. Savera AT, Prasad AR, Zarbo RJ. Myoepithelial carcinoma of the breast: A clinicopathological study of 18 cases. Modern Pathology 13(1):46;2000
19. Prasad AR, Seetharaman M. Respiratory Distress caused by a Hydatid Cyst. Archives Pathology & Laboratory Medicine 125(4):580;2001
20. Prasad AR, Tazelaar HT, Cagle PT, Dail DH, Watts JE. Giant cell tumors of the lung. Modern Pathology 14(1):392;2001
21. Prasad AR, Divine G, Zarbo RJ. Two color cytokeratin labeled DNA flow cytometric analysis of 332 breast cancers: lack of prognostic value with 7-12 year follow-up. Archives Pathology & Laboratory Medicine. 125(3):364-374;2001
22. Savera AT, Prasad AR, Zarbo RJ. Oncocytic Myoepithelioma of salivary glands:An under recognized Variant. Modern Pathology
15(1): 224; 2002
23. Parrett TJ, Prasad AR, Raslan W, Kakar S, LewisJE. Long term and Life-long Follow-up in Polymorphous Low Grade Adenocarcinoma. Modern Pathology 15(1): 223; 2002
24. Andres M, Amin M, Malhotra R, Wilson J, Soundarajan S, Prasad AR. p.63 vs. Other Putative Myoepithelial Immunohistochemical (IHC) Markers in the Diagnosis of Pseudoinvasive Epithelial Lesions and Invasive Tubular Carcinoma (TC) in Small Breast Biopsies. Modern Pathology 16(1):40;2003.
25. Herbst A, Padilla M, Prasad AR, Morales M, Copeland J. Cardiac Wegener’s granulomatosis
masquerading as left atrial myxoma. Annals Thoracic Surgery 75:1321-1323;2003
26. Prasad AR, Tangella KV, Lloyd RV. In situ hybridization for the identification of coccidioides immitis in paraffin embedded tissue section. Modern Pathology 16(1):1128; 2003
27. Andres MW, Amin MA, Freidman T, Malhotra KR, Prasad AR. Characterization of small foci of atypical glands in prostate needle biopsies using double immunostaining with polyclonal a-methylacyl-CoA racemase and high molecular weight cytokeratin. Modern Pathology (16(1):134:2003
28. Simpson RHW, Prasad AR, Lewis JE, Skalova A, David L. Mucin-rich variant of salivary duct carcinoma- a clinicopathologic and immunohistochemical study of four cases. American Journal of Surgical Pathology. 27(8):1070-1079;2003
29. Kay PA, Parrett TJ, Olsen KD, Prasad AR, Lewis JE: C-kit Expression in Polymorphous Low-Grade Adenocarcinoma and Adenoid Cystic Carcinoma. Modern Pathology, 16 (1), 62; 2003
30. Dvorakova K, Payne C, Ramsey L, Holubec H, Sampliner R, Dominguez J, Dvorak B, Bernstein H, Bernstein C, Prasad AR, Fass R, Cui H, Garewal H. Increased expression and secretion of interleukin-6 in patients with Barrett’s esophagus. Clinical Cancer Research 10:2020-2028;2004
31. Dvorakova K, Payne C, Ramsey L, Bernstein H, Holubec H, Sampliner R, Bernstein C, Prasad AR, Garewal H. Apoptosis resistance in Barrett’s esophagus: ex vivo assay of live stressed tissues.
American Journal Gastroenterology 100:424-431;2005
32. Schmelz M, Moll R, Hesse U, Prasad AR, Gandolfi JA, Hasan SR, Bartholdi M, Cress A. Identification of a stem cell candidate in the normal human prostate gland. European Journal of Cell Biology. 84:341-354;2005
33. Shen L, Kondo Y, Hernandez N, Rosner GL, Xiao L, Vilaythong J, Houlihan S, Krouse R, Prasad AR, Einspahr J, Buckmeier J, Alberts D, Hamilton S, Issa J-P. MGMT promoter methylation and field defect in sporadic colorectal cancer. Journal National Cancer Institute. 97:1330-1338;2005
34. Sampliner RE,Camargo L, Prasad AR. Association of ablation of Barrett’s esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia. Diseases of Esophagus. 19:277-279;200
35. Bernstein H, Prasad AR, Holubec H, Bernstein C, Payne CM, Ramsey L, Dvorakova K, Wilson M, Warneke JA, Garewal H. Reduced Pms2 expression in non-neoplastic flat mucosa from patients with colon cancer correlates with reduced apoptosis competence. Applied Immunohistochemistry and Molecular Morphology. 14(2):166-72;2006
36. Sharma P, Wani S, Weston AP, Bansal A, Hall M, Mathur S, Prasad AR, Sampliner RE. A
randomized controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation vs. argon plasma coagulation in combination with acid suppression: long term results. GUT. 55:1233-1239;2006
37. Christensen DO, Prasad AR. Clinicopathologic and Immunohistochemical features of Aggressive Cutaneous Squamous Cell Carcinomas. Modern Pathology 19 (1), 78; 2006
38. Dvorak K, Ramsey L, Payne CM, Sampliner R, Fass R, Bernstein H, Prasad AR, Garewal H. Abnormal expression of biomarkers in incompletely ablated Barrett’s esophagus. Annals Surgery 244(6):1031-1036;2006
39. Dvorakova K, Ramsey L, Sampliner R, Camargo L, Payne CM, Fass R, Bernstein H, Bernstein C, Prasad AR, Garewal H. Activation of the IL-6/STAT3 anti-apoptotic pathway in esophageal cells by bile acids and low pH: relevance to Barrett’s esophagus. Clinical Cancer Research. 13:5305-5313;2007
40. KamradtJ, EinspahrJ, Davis S,Alberts D, Krouse RS, PrasadAR, Meltzer P. Comparing gene expression of histological normal colon mucosa distant and adjacent to colorectal cancer. Proc American Association Cancer Research 47:??-??; 2006
41. Prasad AR, Steck JK, Dellon, AL. Zone of traction injury of the common peroneal nerve. Annals Plastic Surgery 59(3):302–306;2007
42. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, Holubec H, Sampliner
RE, Naisuan G, Condon A, Bernstein C, Green SB, Prasad AR, Garewal H. Bile acids in
combination with low pH induced oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s esophagus. GUT 56(6):763-771;2007
43. Ambrogio C, Lowman X, Kuo M, Malo J, Prasad AR, Parthasarathy S. Determinants of minute ventilation during non-invasive ventilation of patients with respiratory insufficiency. Chest 132(4):647;2007
44. Boolchand V, Fernandez DR, Guillén-Rodríguez JM, Camargo L, Prasad AR, Sampliner RE. Is there a preferred location of intestinal metaplasia in Barrett’s esophagus? Gastrointestinal Endoscopy 165(5): 2007
45. Alberts DS, Einspahr G, Krouse RS, Prasad AR, Ranger-Moore J, Hamilton P, Ismail A, Lance P, Goldschmid S, Hess LM, Yozwiak M, Bartels HG, Bartels PH. Karyometry of the colonic mucosa. Cancer Epidemiology Biomarkers Prevention 16(12):2704-2716;2007
46. Leon LR, John HD, Psalms SB, Guerra R, Biswas A, Prasad AR, Krouse RS. Portomesenteric reconstruction during whipple procedures: review and report of a case. European Journal of Vascular and Endovascular Surgery. 41(6):537-546;2008
47. Rial NS, Lazennec G, Prasad AR, Krouse RS, Lance, MP, Gerner EW. Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colon cancer. International Journal Cancer 124(10):2270-2280; 2009
48. Bartels PH, Krouse RS, Prasad AR, Yozwiak M, Liu Y, Bartels HG, Alberts DS. Actinic damage in histopathologically normal skin. AQCH 30(6):316-22;2008
49. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, Holubec H, Sampliner
RE, Naisuan G, Condon A, Bernstein C, Green SB, Prasad AR, Garewal H. Expression of bile acid
transporting proteins in Barrett’s esophagus and esophageal adenocarcinoma. American Journal of Gastroenterology 104(2):302-313;2009
50. Ambrogio C, Lowman X, Kuo M, Malo J, Prasad AR, Parthasarathy S. Sleep and non-invasive ventilation in patients with chronic respiratory insufficiency. Intensive Care Medicine 35(2):306-313;2009
51. Betsou F, Barnes R, Burke T, Coppola D, DeSouza Y, Eliason J, Glazer B, Horsfall D, Kleeberger C, Lehmann S, Prasad AR, Skubitz A, Somiari, Gunter E [International Society for Biological and Environmental Repositories (ISBER) Working Group on Biospecimen Science]. Human biospecimen research: experimental protocol and quality control tools cancer. Epidemiology Biomarkers Prevention 18(4):117-125;2009
52. Delis A, Pollard CM, Prasad AR, Sobonya RE, Leon L. Isolated superficial temporal artery dissection masquerading as giant cell arteritis. Vascular 17(5):296-299;2009
53. Krouse R, Alberts DS, Prasad AR, Bartels HG, Bartels PH. Progression of skin lesions from normal skin to squamous cell cancer. Anal Quant Cytol Histol 31(1):17-25;2009
54. Jensen V, Prasad AR, Smith A, Raju M, Wendel C, Schmelz M, Leyva W, Warneke J, Krouse R. Prognostic value of immunohistopathological analysis of non-well differentiated squamous cell cancer of the skin. Journal Surgery Research 159(1):509-516;2010
55. Sekulic S, Kim Y, Hostetter G, Savage S, Einspahr JG, Prasad AR, Sagerman P, Alberts DS,
Pittelkow MR, Nickoloff B, Trent JM, Bittner M: Loss of Inositol polyphosphate-5-phosphatase (INPP5A) is Associated with Development and Progression of Cutaneous Squamous Cell Carcinoma (SCC). Cancer Prevention Research. 3(10):1277-1283; 2010
56. Hostetter G, Kim SY, Savage S, Gooden C, Barrett M, Zhang J, Watanabe A, Einspahr J, Alberts DS, Prasad AR, Carpten J, Trent J, Bittner M. Randon DNA fragmentation allows detection of single-copy, single-exon alteration of copy number by oligonucleotide array CGH in clinical FFPE samples. Nucleic Acids Research 38(2):1-12;2010
57. Betsou F, Lehmann S, Ashton G, Barnes M, Benson E, Coppola D, DeSouza Y, Eliason J, Glazer B, Guadagni F, Harding K, Horsfall D, Cynthia Kleeberger C, Nanni U, Prasad AR, Shea K, Skubitz A, Somiari S, Gunter E. Standard Preanalytical Coding for Biospecimens: Defining the Sample Preanalytical Code (SPREC) Cancer Epidemiol Biomarkers Prev. 19(4):1004-11;2010
58. Glazer ES, Bartels PH, Prasad AR, Yozwiak ML, Bartels HG, Einspahr JG, Alberts DS, Krouse RS. Nuclear Morphometry Identifies a Distinct Aggressive Cellular Phenotype in Cutaneous Squamous Cell Carcinoma. Ca Prev Res epub June 2, 2011, DOI:10.1158/1940-6207.CAPR-10-
0404 NIHMS 300358
59. Jensen V, Prasad AR, Gruessner AC, Schmelz M, Leyva WH, Krouse RS. Aggressive Squamous
Cell Cancer of the Skin: Clinical, Pathologic, and Immunohistochemical Predictors of Recurrence.
Annals of Surgery 2012
60. Prasad AR, Thompson P, Hogan M. Nanoparticle Technology for DNA Methylation Analysis. Journal of Biopreservation and Biobanking 2012
61. Taylor Z, Prasad AR, Leon L. Aneurysm of the Great Saphenous vein presenting with pulmonary embolism and a thigh Mass. Texas Heart Journal 2011 ( Accepted) 2012
62. Einspahr JG, Calvert V, Alberts DS, Curiel-Lewandrowski C, Warneke J, Krouse R, Stratton SP, Liotta L, Longo C, Pellicani G, Prasad AR, Sagerman P, Bermudez Y, Deng J, Bowden T, Petricoin III EF. Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma. Cancer Prev. Res.2012; March 5(3): 403-413.
63. Facista A, Nguyen H, Lewis C, Prasad AR, Ramsey L, Zaitlin B, Nfonsam V, Krouse RS, Bernstein H, Payne CM, Stern S, Oatman N, Banerjee B, Bernstein C. Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer. Genome Integr. 2012 Apr 11;3(1):3.
64. Goldberg M, Buckmeier JA, Prasad AR, Alberts DS, Krouse RS, Diamond AM. Loss of heterozygosity at the Glutathione Peroxidase-1 locus is not an early event in colon carcinogenesis. Genes & Cancer. 2011: 2(9):910-913
65. Bartels P.H., Bartels H.G., Albert, D.S., Yozwiak, M., Prasad, A.R., Glazer, E., Krouse, R Karyometry of nuclear phenotypes in cutaneous squamous cell carcinoma. Analytical and
Quantitative Cytology and Histology, 2012, Feb; 34(1);1-8
66. Bernstein C, Nfonsam V, Prasad AR, Bernstein H. Epigenetic field defects in progression to cancer. World J Gastrointest Oncol. 2013 Mar 15;5(3):439.PMID:23671730[PubMed]
67. Prasad AR, Prasad S, Nguyen H, Fascista A, Lewis C, Zaitlin B, Bernstein H and Bernstein C Novel Diet-related Mouse Model of Colon Cancer Parallels Human Colon Cancer World J Gasrointest Oncol. 2013 Sept
68. Brushing cytology with adjunctive FISH and biomarker analyses is highly sensitive and specific in the early detection of low-grade dysplasia in Barrett’s Esophagus Yimin Dong MD. PhD. , Jing Zhai Jonathan Prunean Pharm D. , Daniel Megna MD. , Ashish Prasad , Sam Moussa MD. , David Baunoch PhD. , Anil Prasad MD. Modern Pathology, March 2017
69. Implications of a Negative Confirmatory Biopsy among Men on Active Surveillance for Prostate Cancer along with PTEN/ERG as a Predictor of Pathologic Progression. Kirk Lin, Anil Prasad, Modern Pathology March 2021
70. New Panel of Molecular/Cellular Markers of Prostate Cancer for Risk Stratification. Kirk Lin, Anil Prasad, Modern Pathology March 2021
71. CINtec®PLUSCytology Assay is an objective biomarker triage test for ASC-US and LSIL Pap cytology results. A study of 242 HPV-positive women with follow up colposcopy/cervical biopsy results. Haind M Fadel, Priya L. Verma, Anil R. Prasad; Archives of Pathology & Laboratory Medicine October 2023
72. Negative Confirmatory Biopsy among Men on Active Surveillance for Prostate Cancer along with PTEN/ERG as a Predictor of Pathologic Progression. Haind M Fadel, Priya L. Verma, Anil R. Prasad; Archives of Pathology & Laboratory Medicine October 2023
Invited Reviews
Fishing for Bladder Cancer. A.R. Prasad. Invited Review for Newsletter,Arizona Society of Pathologists. Vol. 15,
No.1, pg. 6-7, Feb 2004.
Book Reviews
Head and Neck Pathology with Clinical Correlations. Edited by Yao-Shi Fu, et al. American Journal of Surgical Pathology, 25(12): 1560-1564, 2001.
Book Chapters
M. Schmelz and A.R. Prasad. CK 6 expression in prostate stem cells. In “Cell Adhesion and Cytoskeletal Molecules in Metastasis“. A. Cress and R. Nagle (Editors) Springer Science & Business Media, Dordrecht, The Netherlands, published October 2006.
A.R. Prasad, Section Editor: MDT Approach to Rare Cancers in the Abdomen. In Multidisciplinary Team Approach to Diagnosis and Treatment of Gastrointestinal Diseases. J. Jankowski, Y. Fong, R. Sampliner (Eds.) Oxford University Press, London, UK. Published August 2008.
Carol Bernstein, Anil R. Prasad, Valentine Nfonsam, Harris Bernstein. DNA Damage, DNA Repair and Cancer. Chapter in “DNA Repair-New Research Directions,” editor Clark Chen, Rijeka; InTech; 2012, (ISBN 980-953-307-746-3)
Scholarly Presentations at National Meetings
Platform Presentations
Novel smooth muscle specific proteins in salivary gland tumors. A.R. Prasad, A.M. Gown and R.J. Zarbo. 87th Annual Meeting of US and CanadianAcademy of Pathology; Boston, MA. March 1998.
Ductal Carcinoma In-situ: Correlation of residual disease with margin status and Van Nuys Prognostic Index. A.R. Prasad, P. Ramalingam and U.R. Raju. 88th Annual Meeting of US and CanadianAcademy of Pathology; San Francisco, CA. March 1999.
Immunohistochemical demonstration of myoepithelial cell participation in salivary gland basal cell and canalicular adenoma. A.R. Prasad, A.T. Savera, J.A. Regezi, A.M. Gown and R.J. Zarbo. 88th Annual Meeting of US and CanadianAcademy of Pathology; San Francisco, CA. March 1999.
Shen L, Kondo Y, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP: Epigenetic inactivation of MGMT defines a field defect in sporadic colorectal cancer. American Association for Cancer Research Annual Meeting, March 27-31, 2004, Orlando, FL.
Comparing gene expression of histological normal colon mucosa distant and adjacent to colorectal cancer.J. Kamradt,J. Einspahr, S. Davis, D.Alberts, R.S. Krouse, A.R. Prasad and P.Meltzer.AnnualAACR Meeting. 2005.
Peroneal Nerve Stretch/Traction Zone of Injury Extends to Neuromuscular Region of Muscle, Preventing Success of Nerve Grafting for Foot Drop. A.R. Prasad and A.L. Dellon. Annual Meeting of American Society for Peripheral Nerve Disease; Tucson, AZ. January 2006.
Innovative Methods of DNA Extraction from Paraffin-Embedded Tissue Using Nanoparticle Technology. A.R. Prasad, M. Schmelz, M. Hogan, P. Thompson and M. Utermohlen. International Society of Biological and Environmental Respositories; Washington, DC. April 2006.
Prognostic Value of Immunohistopathological Analysis of Non-Well Differentiated Squamous Cell Cancer of the Skin Vanessa Jensen, MD; Anil Prasad, MD; Aaron Smith, MD; Menaka Raju, MD; Christopher, Wendel, MS; Monika Schmelz; William Leyva, MD; James Warneke, MD; Robert Krouse, MD. Association of VA Surgeons; Little Rock, AR. May 2007.
Kim SY, Nickoloff B, Prasad A, Krouse R, Alberts DS, Einspahr JG, Bittner M. Application of
microarray-based comparative genomic hybridization on archival tissues of cutaneous squamous cell carcinomas. Society for Investigative Dermatology, May 9-12, Los Angeles, CA, 2007.
Smith A, Prasad A, Jensen V, Wendel CS, Kapali M, Raju M, Schmelz M, Leyva W, Krouse RS. Aggressive Squamous Cell Cancer of the Skin: Clinical, Pathologic, and Immunohistochemical Predictors of Survival. Association of VA Surgeons Annual Meeting, May 4-6, 2008, Dallas, TX.
Higa G, Prasad A, Wendel C, Krouse RS. Does Sentinel Lymph Node Mapping Have a Role for Cutaneous Squamous Cell Carcinoma? Academic Surgical Congress, February 3-6, 2009, Fort Myers, FL.
Einspahr JG, Valvert V, Olson E, Curiel-Lewandrowski C, Longo C, Deng J, Lance L, Pellicani G, Alberts DS, Krouse R, Prasad A, Bowden T, Petricoin EF. Protein network analysis of acutely UV-irradiated mouse skin and human samples representing the progression of cutaneous SCC. Society for Investigative Dermatology Annual Meeting, May 6-9, 2009, Montreal, Quebec, Canada.
Glazer E, Bartels H, Yozwiack M, Prasad A, Alberts D, Krouse R Validation of Quantitative Histopathology in Identifying Aggressive Cutaneous Squamous Cell Carcinoma 7th Annual Academic Surgical Congress Las Vegas, NV, Feb 14-16, 2012.
Poster Presentations
Significance of acid – mucin secreting columnar cells in gastroesophageal junctional mucosa.
A.R. Prasad, C.K. Ma, M.N. Lee and M.B. Amin. 87 th Annual Meeting of US and Canadian Academy of Pathology; Boston, MA. March 1998.
Antimitochondrial antibody – a diagnostic discriminant of salivary gland oncocytic tumors and acinic cell carcinomas. A.R. Prasad, A.T. Savera and R.J. Zarbo. 88th Annual Meeting of US and Canadian Academy of Pathology; San Francisco, CA. March 1999.
Retrorectal Cystic Hamartoma: Clinicopathologic study of six cases, with associated malignancy in two. A.R. Prasad, C.K. Ma, T.L. Randolph and M.B. Amin. American Society of Clinical Pathologists, Spring Meeting; Los Angeles, CA. April 1998.
High grade, peripheral gamma – delta T cell lymphoma with generalized lymph node and widespread organ involvement. B. Singh and A.R. Prasad. American College of Physicians, Annual Meeting; Michigan.1998.
Thyroid Transcription Factor-1 (TTF-1) is a more sensitive lung carcinoma marker than surfactant APOA1. S.K. Anderson, D.J. Langel, A.M. Gown, A.R. Prasad, A. Savera and R.J. Zarbo. 87th Annual Meeting of USCAP; Boston, MA. March 1998.
Two color cytokeratin labeled DNA flow cytometric analysis of 332 Breast Cancers: Lack of prognostic value with 7-12 year follow up. A.R. Prasad, G. Divine and R.J. Zarbo. 89th Annual Meeting of US and Canadian Academy of Pathology; New Orleans, LA. March, 2000.
Myoepithelial carcinoma of the breast: A clinicopathological study of 18 cases. A.T. Savera, A.R. Prasad and R.J. Zarbo. 89th Annual Meeting of US and Canadian Academy of Pathology; New Orleans, LA. March 2000.
Giant cell tumors of the lung. A.R. Prasad, H.T. Tazelaar, P.T. Cagle, D.H. Dail and J.E. Watts. 90th Annual Meeting of US and Canadian Academy of Pathology; Atlanta, GA. February 2001.
Oncocytic Myoepithelioma of salivary glands: An under-recognized Variant. A.T. Savera, A.R. Prasad and R.J. Zarbo. 91st Annual Meeting of US and Canadian Academy of Pathology; Chicago, IL. March 2002.
C-kit Expression in Polymorphous Low-Grade Adenocarcinoma and Adenoid Cystic Carcinoma. P.A. Kay, T.J. Parrett, K.D. Olsen, A.R. Prasad, J.E. Lewis. 91st Annual Meeting of US and Canadian Academy of Pathology; Chicago, IL. March 2002.
Long term and Life-long Follow-up in Polymorphous Low Grade Adenocarcinoma. T.J. Parrett, A.R. Prasad, W. Raslan, S. Kakar and J.E. Lewis. 91st Annual Meeting of US and Canadian Academy of Pathology; Chicago, IL. March 2002.
In Situ Hybridization for the Identification of Coccidioides Immitis in Paraffin Embedded Tissue Sections. A.R. Prasad, K.V. Tangella and R.V. Lloyd. 92nd Annual Meeting of US and Canadian Academy of Pathology; Washington, DC. March 2003.
Characterization of Small Foci of Atypical Glands in Prostate Needle Biopsies using Double
Immunostaining with Polyclonal a–Methylacyl (Racemase CoA and High Molecular Weight Cytokeratin). M.W. Andres, M.A. Amin, T. Freidman, K.R. Malhotra and A.R. Prasad. 92nd Annual Meeting of US and Canadian Academy of Pathology; Washington, DC. March 2003.
Increased expression and secretion of IL-6 in patients with Barrett’s esophagus. K. Dvorakova, C. Payne, L. Ramsey, R. Sampliner, H. Holubec, H. Bernstein, C. Bernstein, C. Waltmire, B. Dvorak, A.R. Prasad and H. Garewal. 94th Annual Meeting of AACR; Washington, DC. July 2003.
Immunohistochemical differentiation of polymorphous low grade adenocarcinoma and adenoid cystic carcinoma. A.R. Prasad, R. Zarbo, J. Lewis and L. Thompson. Annual Meeting of American Society of Clinical Oncology; Chicago, IL. September 2003.
Clinico-Cytopathologic Features of Pulmonary Coccidiodomycosis: A Study of 52 cases. M.T. Padilla, M.W. Andres, R.E. Sobonya and A.R. Prasad. 93rd Annual Meeting of US and Canadian Academy of Pathology; Vancouver, BC Canada. March 2004.
Diagnostic Validity of Pathology Virtual Slide Diagnosis for GI Spore. A.K. Bhattacharyya, C. Pettis, A.R. Prasad and M. Nelson. GI SPORE Annual Meeting; Memphis, TN. 2005.
Automated FISH Staining for Her-2/neu. J. Sanford, M. Wang, D. Wolk and A.R. Prasad. Association of Molecular Pathology Annual Meeting; Florida. November 2004.
Clinicopathologic and Immunohistochemical Features of Aggressive Cutaneous Squamous Cell Carcinomas. D. Christensen and A.R. Prasad. 95th Annual Meeting of US and Canadian Academy of Pathology; Atlanta, GA. February 2006.
Is there a preferred location of Intestinal Metaplasia in Barrett’s Esophagus? Vikram Boolchand, Diane Fernandez, Lisa Camargo, Anil Prasad, Richard E. Sampliner, Digestive Disease Week, Annual Meeting, Washington, DC. May 2007.
Clinicopathological & Immunohistochemical features of Squamous cell carcinomas of the lip.
Jeffrey Pat, Menaka Raju, Robert Krouse, William Leyva & Anil Prasad 98th. Annual Meeting of US and Canadian Academy of Pathology; Boston, MA. March 2009.
Immunopathological features of Cutaneous Squamous Cell Carcinomas in Immunocompromised patients. Carlo
Valentino, Robert Krouse, Deborah Bradley-Dunlop, Ray Nagle, Emmanuel Akporiaye & Anil Prasad 98th Annual Meeting of US and Canadian Academy of Pathology; Boston, MA. March 2009.
Brushing cytology with adjunctive FISH and biomarker analyses is highly sensitive and specific in the early detection of low-grade dysplasia in Barrett’s Esophagus Yimin Dong MD. PhD. , Jing Zhai , Jonathan Prunean Pharm D. , Daniel Megna MD. , Ashish Prasad , Sam Moussa MD. , David Baunoch PhD. , Anil Prasad MD. Best Abstract Travel Award for 106th Annual Meeting of US and Canadian Academy of Pathology; March 2017 San Antonio, Texas.
Invited Lectures – International
JIPMER (Jawaharlal Institute of Postgraduate Medical Education & Research) Scientific Society;
Pondicherry, India. July 2003. Title: Colorectal Cancer: Essentials of diagnosis and Prognosis.
AVMC Medical College & Hospital; Pondicherry, India. Pathology Update, February 2004.
Title: Surgical Pathology of Thyroid and Lung Tumors.
General Hospital, Pondicherry; Pondicherry, India. February 2004. Title: Current Trends in Pathology: Bench to Bedside.
Oxford Radcliffe Hospitals, NHS Trust; Oxford, London, UK, Department of Cellular Pathology. June 2004. Title: Tissue Biorepository Management.
University of Wales; Cardiff, Wales, UK. June 2004. Title: Fishing for Bladder Cancer.
Dept. of Veterans Affairs, Research Advisory Committee Meeting on Gulf War Veterans’ Illnesses, Dallas,TX, November 2006. Title: Gulf War Brain bank.
International Academy of Pathology, Indian Division; Bangalore, India. December 2006. Title: Telepathology of Surgical Pathology of Head & Neck Tumors.
National University of Singapore, Singapore. May 2007. Title: Evolution of Telemedicine.
Pondicherry Institute of Medical Sciences, Pondicherry, India. June 2007. Title: Surgical Pathology of Hereditary GI Tumors.
University of Malaysia, Kuala Lumpur. July 2007. Title: Telepathology: History and Utility.
Kidwai Memorial Institute of Oncology, Bangalore, India, Annual CME Conference in GI Pathology February 2008 Title: Surgical Pathology of Hereditary GI tumors.
International Society of Biological & Environmental Repositories (ISBER) Annual Meeting Plenary Speaker, Washington DC, May 2008: Title: Academic Biobanks & the Corporate Sector.
Stem Cell World Congress Annual Meeting Plenary Speaker, Palm Springs, USA, January 2009 Title: Biorepositories: A Critical Resource: Issues, Challenges & Opportunities.
AIPNA-Indian Congress of Pathology Annual Meeting, Bhopal, India, February 2019. Title: Surgical Pathology of Head & Neck tumors.
All India National Pathology Conference (APCON), Northwest Chapter, Amritsar, India February 2019 Sri Gurudas man Medical College Title: Quality Control in Anatomic Pathology
Invited Lectures – Regional
Tucson Pathology Society; SAVAHCS, Tucson, AZ. February 2002. Title: Solitary Fibrous Tumors.
Tucson Pathology Society; SAVAHCS, Tucson, AZ. February 2003. Title: Fishing for Bladder Cancer.
University of Arizona Health Science Center, Department of Pathology Faculty Research Retreat; Tucson, AZ. May 2003. Title: Microsatellite Instability in Colorectal Cancer.
Sanofi Synthelabo. Western Region Preceptorship Phase IV/V Training Program, AZCC; Tucson, AZ. September 2003. Title: Pathology of Pancreatic Cancers.
Squamous Cell Carcinoma of the Skin: Issues and Opportunities. Grand Rounds, University of Arizona Department of Surgery, May 12, 2004, Tucson, AZ.
Southwest VA Health Care Network (VISN 18) Research Forum; Tucson, AZ. March 2005. Title: A New Prostatic Epithelial Cell Phenotype: A Stem cell Candidate?
Sanofi Synthelabo. Western Region Preceptorship Phase IV/V Training Program, AZCC; Tucson, AZ. October 2005. Title: Anatomy & Pathology of Colorectal Cancers.
Frontiers in Medical Research Datablitz, Univ. of Arizona College of Medicine Research Office, AZCC, Tucson, March 2007 Title: VA Healthcare Research at SAVAHCS
Arizona Translational Resource Network(AzTransNet), Battelle Corporation/Flinn Foundation, Phoenix, AZ, January 2007. Title: The Tissue Issue; Ethical and Legal Issues in Biorepository Research.
VISN 18 Research Forum, New Mexico Health Care System, Albuquerque, NM, May 2007. Title:
National VA Biorepository Trust.
Sanofi Synthelabo. Western Region Preceptorship Phase IV/V Training Program, AZCC; Tucson, AZ. October 2007. Title: Pathology of Colorectal Neoplasms.
Tissue Donor Awareness Program (TDAP), Arizona Myeloma Network, Tucson, AZ, November 2007. Title: Utility of Tissue in Cancer Research.
Southwest VA Health Care Network (VISN 18) Research Forum; Tucson, AZ. March 2008. Title: National VA Biorepository Trust; Genomics & Veteran’s Health.
Arizona Society of Cytotechnologists, Tucson, AZ. November 2008 Title: Fishing for Bladder Cancer.
Provena Medical Center, Champaign, Urbana, IL Staff Scientific Meeting, October 2010: Molecular Diagnostics for Bladder Cancer Including latest Bladder Cancer Staging Guidelines.
American Society for Cytotechnology, 2013 Annual Scientific Conference, Scottsdale, AZ, April 19th-21st, 2013: Talk & Workshop: 1. History & Advances in Telepathology; 2. Skills/Tools Required to be a Good Laboratory Manager.
Arizona Society of Pathologists, 2013 Annual Fall Meeting, Mayo Clinic, Scottsdale, AZ October 26th Urine Cytology: Morphological Diagnosis with FISH as a diagnostic adjunct.
Grant Support, Federal
7/23/2003-7/22/2005
PO1 CA 41108; Alberts (PI)
$0 5% effort NIH Detection of Methylated Tumor Suppressor Genes in Colorectal Tumors and Matched Plasma Samples: Development of a potential marker of colorectal cancer in the plasma. The major goals of this program are to develop new preventive strategies to prevent colon cancer and to reduce the morbidity and mortality rate caused by colorectal cancer.
Role: Co-investigator.
2002-2007
P50 CA 95060; Gerner (PI); $2,803,847; 4% effort; 4/1/2002 – 3/31/2007
NIH Specialized Program of Research Excellence (SPORE) in GI. The goal of this interdisciplinary Specialized Program of Research Excellence in GI cancer is to prevent and cure GI cancers through studies in prevention, genetics and therapeutics.
Role: Co-investigator.
2002-2004
NCI contract #N01-CN85185 Sampliner(PI) $50,000; 5% effort 6/30/02-7/1/04
Chemoprevention for Barrett’s Esophagus Trial (CBET), (collaboration with John Hopkins University Hospital Research Center, Baltimore, MD).
Role: Co-Investigator.
2004-2005
VISN 18 (10N18); Prasad (PI); $37,300; 10% effort 4/1/2004 – 3/31/2005
New Investigator Pilot Grant. Department of Veterans Affairs. A New prostatic epithelial cell phenotype: a stem cell candidate. This projects characterized the properties of a new prostate epithelial cell type and demonstrated that this new cell type possesses stem cell characteristics.
Role: Principal Investigator.
2004-2008
W81XWH-04-1-0921; Schmelz (PI); $275,000; 5% effort; 10/15/04 – 10/14/08
Department of Defense. The Plasticity of Human Normal Prostate Glandular Homeostasis. This project investigates the role of growth factors in the regulation of cytokeratin 6 positive cells, a
newly discovered prostatic epithelial cell type.
Role: Co-investigator.
2004-2009
PO1 CA 27502-21; Alberts (PI); $14,668,115; 1% effort; NIH 7/1/2004 – 6/30/2009
Quantitative Relationship of Histopathologic Changes, Genotypic Changes,
Immunohistochemical Surrogate Endpoint Biomarkers (SEBS), and Morphometric Changes to Multistep Carcinogenesis in Skin Cancer. This project studies patterns of gene expression, karyometric changes and biomarker expression in actinic keratosis and squamous cell carcinoma of the skin.
Role: Co-investigator
2005-2006
VISN 18 (10N18); Leyva (PI); $40,000; 15% effort; 7/1/2005 – 6/30/2006
New Investigator Pilot Grant, Department of Veterans Affairs. Patterns of Gene
Expression, Clinicopathologic and karyometric Features of Cutaneous Squamous Cell
Carcinoma in Immunosuppressed Patients. The goal of this project is to study clinical
and pathological features of aggressive cutaneous squamous cell carcinoma along with gene expression patterns.
Role: Co-Principal Investigator.
2005-2007
R21 PA03-003 Payne(PI) $301,500; 5% effort NIH 7/1/05-6/30/07
Cytochrome C Oxidase1: A Biomarker for colon cancer risk
Role: Co- Investigator
2005-2009
PO1 CA 41108; Lance (PI) $18,143,081; 2% effort; NIH/NCI 8/1/05-9/14/09
Colon Cancer Prevention Program Project. The major goals of this program are to develop new preventive strategies to prevent colon cancer and to reduce the morbidity and mortality rate caused by colorectal cancer.
Role: Co-Investigator.
2006-2009
CSP# 501; Prasad (P.I.); $1,000,000; 15% effort 3/1/2006 – 2/28/2009
Department of Veterans Affairs Cooperative Studies Program. The Veterans Affairs Gulf
War Biorepository Trust. The goal of this project is to establish a human tissue
biorepository center for Gulf War veterans’ tissues with annotated clinical data for
translational research.
Role: Principal Investigator
2008-2009
Department of Veterans Affairs Cooperative Studies Program. Dawn Provenzale (P.I.) $688,000; 20% 4/1/08-3/31/09
VA Cancer Tissue Repository and Linked Epidemiological and Clinical Database
To establish a genomic medicine resource within CSP to advance cancer research
and healthcare for veterans.
Role: Co-PI
Peter Patterson, MD
Medical Director
Peter Patterson, MD
Medical Director
Dr. Patterson is a third-generation physician broadly trained in both medicine and business management. He brings the perspectives of a practicing physician-manager to his work with Arizona Diagnostic Pathology Associates.
Dr. Patterson received his M.D. from the University of Alberta in 1967 and holds board-
certification in Pathology in both Canada and the U.S. He received his M.B.A. from the
University of Calgary in 1987 and was among the first physicians to achieve board-certification in medical quality assurance in 1991.
Dr. Patterson has an extensive background and experience in medical quality improvement, lean six sigma and clinical information systems. He is an accomplished physician-leader and has served in many roles – including laboratory medical director,
chair of hospital-wide quality assurance and physician Lean champion.
Rajal Shah, MD
Senior Pathologist
Rajal Shah, MD
Senior Pathologist
Dr. Shah is board certified in anatomic and clinical pathology. He received his medical degree and completed his residency in pathology and microbiology at Gujarat University, India. He was a resident physician in anatomic and clinical pathology at St. John Hospital and Medical Center in Detroit, MI and completed his fellowship in genitourinary and surgical pathology at the University of Michigan. Dr. Shah is currently the President of the Genitourinary Pathology Society (GUPS) and ADPA is proud to recognize him as our Honorary Advisor.
Suma Prasad
CEO
Suma Prasad
Chief Executive Officer
Suma Prasad is the Chief Executive Officer of Arizona Diagnostic Pathology Associates, a state-of-the-art, CLIA-certified & CAP-accredited specialty laboratory. Under Suma’s management, ADPA has forged strong partnerships with physicians, local clinics, and other healthcare networks in Arizona and California. Suma’s client-centered approach and advocacy for efficient team communication has allowed ADPA to expand its capabilities. At the heart of Suma’s leadership is a simple belief: when you take care of people—the team, the partners, the patients—the science follows.
Rebecca Stroud, HT (ASCP)
AP Lab Manager
Rebecca Stroud, HT (ASCP)
AP Lab Manager
Rebecca Stroud is our Laboratory Manager. She has 20+ years in Histology specializing in urology and gastroenterology. Rebecca is also skilled in specialty testing such as immunohistochemistry and FISH testing. She graduated from Phoenix College with an Associate’s in Science and is certified by ASCP as a Histology Tech. On her off time she enjoys spending time with her family and hiking.
Shilpa Prasad, MBA
Director of Marketing & Operations
Shilpa Prasad, MBA
Director of Marketing & Operations
Shilpa Prasad, MBA is a clinical research and laboratory operations leader with a track record of accelerating trial timelines, improving regulatory compliance, and enhancing patient recruitment strategies. As Director of Marketing & Operations for Arizona Diagnostic Pathology Associates, Shilpa blends healthcare operations expertise with strategic marketing to strengthen brand visibility and streamline lab systems. With experience at Cedars-Sinai and other leaders in the pharmaceutical industry, she is known for bridging clinical, regulatory, and business priorities to drive operational excellence and advance patient care.
Ghassan Tranesh, MD, MSc, FCAP
Consultant Pathologist
Ghassan Tranesh, MD MSc, FCAP
Consultant Pathologist
Dr. Ghassan Tranesh, MD, MSc, FCAP is a board-certified surgical pathologist, cytopathologist, and dermatopathologist with extensive expertise in diagnostic pathology, medical education, and research. As a consultant pathologist for ADPA
& through his role as a surgical pathologist at Tucson Pathology Associates, Dr. Tranesh signs out a broad spectrum of surgical pathology cases, with a subspecialty focus on inflammatory and neoplastic dermatopathology, particularly melanocytic
proliferations. During his time as the Medical Director of Cytopathology & Assistant Professor of Pathology at University of Arizona College of Medicine, he fostered a culture of continuous learning and professional growth for his students and developed and implemented image-guided biopsy techniques, improving diagnostic accuracy and enhancing patient care outcomes. A published researcher and dedicated educator, Dr. Tranesh has authored numerous peer-reviewed papers and contributed to major research initiatives in cancer diagnosis and
immunoprevention.
Manju Nath, MD
Consultant Pathologist
Manju Nath, MD
Consultant Pathologist
Dr. Manju E. Nath, M.D. is a board-certified pathologist specializing in anatomic, clinical, and cytopathology and is currently serving as one of the consultant pathologists at ADPA. He completed his medical education at J.J.M. Medical College, University of Mysore, India,
followed by residency and fellowship training in pathology and cytopathology at the University of Pittsburgh. Dr. Nath has held key leadership roles as Medical Director and Staff Pathologist across multiple hospitals, including serving as Assistant Professor of Pathology at the University of Pittsburgh Medical School. A prolific researcher, Dr. Nath has published numerous articles, abstracts, and book chapters on breast and gynecologic pathology and has delivered lectures at
national and regional conferences. He is an active member of several professional societies, including the American Society of Clinical Pathologists, American Society of Cytology, and the International Academy of Pathology, and has held leadership roles in the Pittsburgh Pathology Society.
L S Ram
Business Advisor
L S Ram
ADPA
Ram has been an entrepreneur for most part of his four-decade long career. He founded
his latest venture Exdion Solutions 9 years ago. This venture with 300+ team members, has successfully leveraged AI to build platforms that have disrupted Healthcare &
Insurance Industries in US.
Prior to Exdion, he was the CEO of Crossdomain Solutions with 3000 team members, which he co-founded in 1999.
Most of his ventures have received recognition from Govt of India & Govt of
Karnataka. His ventures have also won several accolades in USA.
He was one of the first IT business leaders in India to build a team in Shimoga, a tier-2 town way back in 2008. His present venture Exdion has a tier-2 center in Vellore with women accounting for over 85% of the staff strength over there. Women have made up a majority in most of his ventures. His CSR initiatives also revolve around creating employment opportunities for girls from lower strata of
the society.
Ram is a Postgraduate in Computer Science and also a Chartered Accountant. He attributes his success to having good parents, great teachers, enjoyable childhood and most importantly, being born in a great country at the right time.
Connie Frank, CLS (ASCP)
Medical Lab Scientist
Connie Frank, CLS (ASCP)
Medical Lab Scientist
I am a certified Medical Laboratory Scientist (ASCP) with a Bachelor of Science in Medical Technology and a strong background in both hospital and clinical laboratory environments. Over the course of my career, I’ve served as a Laboratory Generalist, Technical Coordinator, and Laboratory Supervisor. These roles have allowed me to contribute to Shared Leadership Committees and lead LEAN process improvement initiatives, all with a focus on enhancing laboratory efficiency and patient care.
I am passionate about delivering accurate, high-quality diagnostic results that support clinical decision-making and improve patient outcomes. My approach combines technical expertise with a commitment to continuous improvement and collaborative teamwork.
Outside the lab, I enjoy gardening, birding, attending cultural events and music festivals.
Nahla Tan Alawi, CLS (ASCP)
Medical Lab Scientist
Nahla Tan Alawi, CLS (ASCP)
Medical Lab Scientist
I am a certified Medical Laboratory Scientist (AMT) that graduated in 1991 from the Philippine Women’s University, Manila with a Bachelor of Science in Medical Technology. I have a strong background in both hospital and clinical laboratory environments. Over the course of my career, I’ve served as a Laboratory Generalist and Lead Laboratory Technologist.
I am deeply committed to delivering precise and reliable diagnostic results that empower clinical decision-making and enhance patient care. My work is driven by a strong foundation in technical expertise, a dedication to continuous learning, and a collaborative spirit that fosters effective teamwork.
Emily Alexander
Histology Tech
Emily Alexander
Office Admin
Emily is a Histology Tech here at Arizona Diagnostic Pathology. She is responsible for the grossing, processing and embedding of specimens. She earned her Bachelors of Science in Criminology and Criminal Justice and Masters Degree in Elementary Education. In her free time Emily likes to spend time with her family and go hiking.
Kelsey Frank
Office Admin
Kelsey Frank
Office Admin
Hello, my name is Kelsey! I’m a Medical Office Administrative Assistant here at Arizona Diagnostics Pathology Associates. I work at the reception desk taking calls, labeling specimens as quality control, and preparing slides for Pathology. I’m currently attending Pima College to gain my certification in Medical Billing and Coding. In my down time, I enjoy going golfing, shopping, and being active outdoors!.
Ashlynn Matthews
Phlebotomist and CLA
Ashlynn Matthews
Phlebotomist and CLA
Hello, my name is Ashlynn. I am a CLA here at Arizona Diagnostic Pathology Associates. I have been a CLA/ Phlebotomist for 14 years. My duties here at the lab are receiving specimens, billing, and assisting the lab technologists. Additionally, I draw blood on walk-in patients and at clinics. I was born and raised here in Tucson, AZ. I have two kids and enjoy downtime with my family.
Camile Lujan
Phlebotomist
Camile Lujan
Phlebotomist
My name Is Camille. I started my medical journey in 2008 when I attended a trade school and received my certification as a Medical Assistant, clinical. In 2010 I attended again for my Phlebotomy Technician certification. 2015 I received a Certified Nursing Assistant license. I used myself as an example for my children to see that if you put your mind to it, you can achieve any goal. My goal, my passion is to heal those that need it, mind body and soul.
Why Providers & Patients Choose ADPA
Precision Testing
We use advanced equipment and validated methodologies to ensure consistent accuracy across a broad range of diagnostic specialties.
Pathologist Oversight
As a pathologist-owned lab, every case benefits from expert review by a board-certified pathologist—ensuring accuracy and clinical relevance.
Fast Turnaround
Most cases are processed within 24–48 hours, helping providers and patients get timely answers without compromising accuracy.
Responsive Support
Our team is approachable, attentive, and committed to providing personalized service with every client and clinical partner we serve.
Ready to Partner with ADPA?
ADPA delivers accurate results, fast turnaround, and personalized support.